Inhibiting PP2A-PP2Ac signals was sufficient to significantly block Raf-MEK-ERK activation and reduce glutamine metabolism in endothelial cells, which provided a new direction for the research in endothelial dysfunction. Here, RAF1 is linked to endothelial dysfunction.